Long COVID
Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), refers to a range of new, returning, or ongoing health problems people can experience four or more weeks after first being infected with the virus that causes COVID-19. It shares many clinical similarities with ME/CFS and dysautonomia.
Common Symptoms
Post-exertional malaise (PEM)
Severe fatigue that interferes with daily life
Brain fog and cognitive impairment
Dysautonomia/POTS symptoms (palpitations, dizziness)
Shortness of breath and chest pain
Causes & Triggers
- Viral persistence in tissues
- Immune system dysregulation and autoantibodies
- Reactivation of dormant viruses (e.g., Epstein-Barr Virus)
- Microvascular blood clotting and endothelial dysfunction
- Microbiome disruption
Diagnosis
Currently a clinical diagnosis of exclusion based on history of COVID-19 infection and persistent symptoms lasting beyond the acute phase. Specialized testing may reveal microclots, autoantibodies, or autonomic dysfunction.
Treatment Approaches
Pacing and energy management to prevent PEM
Treating underlying dysautonomia/POTS
Mast cell targeted therapies
Anticoagulant or antiplatelet therapy for microclots
Low Dose Naltrexone (LDN) for neuroinflammation
Not Sure Where to Start?
Take our free Root Cause Assessment to help identify whether your symptoms are primarily driven by genetics, environmental toxins, or nervous system dysregulation.
Take the Free AssessmentTop Long COVID Specialists
Research & Sources
Long COVID: major findings, mechanisms and recommendations
Nature Reviews MicrobiologyView Source
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
eClinicalMedicine (The Lancet)View Source